Australian Clinical Labs Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	382	540	503	694	922	686
Market Cap Growth	-38.18%	7.36%	-27.51%	-24.69%	34.33%	-
Enterprise Value	674	834	805	1,001	1,160	940
Last Close Price	2.02	2.65	2.30	3.04	3.63	2.63
PE Ratio	14.33	16.66	21.03	19.34	5.17	11.37
Forward PE	11.56	13.94	13.83	15.92	9.64	7.42
PS Ratio	0.52	0.73	0.72	1.00	0.93	1.06
PB Ratio	2.53	3.14	2.83	4.02	3.96	8.38
P/TBV Ratio	-	87.92	39.99	95.82	13.75	-
P/FCF Ratio	2.44	3.10	3.29	5.08	3.51	4.75
P/OCF Ratio	2.32	2.96	3.15	4.83	3.25	4.46
PEG Ratio	1.53	0.74	3.00	-	-	-
EV/Sales Ratio	0.91	1.13	1.16	1.44	1.17	1.45
EV/EBITDA Ratio	3.31	10.26	10.55	12.56	4.05	6.80
EV/EBIT Ratio	9.82	12.27	12.87	15.35	4.24	7.34
EV/FCF Ratio	4.30	4.79	5.26	7.32	4.42	6.51
Debt / Equity Ratio	2.09	1.69	1.74	1.83	1.13	3.71
Debt / EBITDA Ratio	1.55	1.42	1.62	1.68	0.69	1.41
Debt / FCF Ratio	2.01	1.67	2.02	2.31	1.00	2.11
Net Debt / Equity Ratio	1.93	1.56	1.59	1.71	1.01	3.27
Net Debt / EBITDA Ratio	3.58	3.30	3.70	3.71	0.82	1.94
Net Debt / FCF Ratio	1.86	1.54	1.84	2.16	0.89	1.85
Asset Turnover	1.29	1.27	1.19	1.16	1.79	1.52
Inventory Turnover	28.26	28.99	27.72	25.32	32.71	32.71
Quick Ratio	0.42	0.44	0.52	0.51	0.53	0.60
Current Ratio	0.59	0.56	0.64	0.62	0.64	0.71
Return on Equity (ROE)	16.68%	18.77%	13.84%	17.79%	113.46%	80.04%
Return on Assets (ROA)	7.48%	7.28%	6.67%	6.75%	30.79%	18.82%
Return on Invested Capital (ROIC)	9.94%	10.29%	8.98%	10.40%	46.95%	29.52%
Return on Capital Employed (ROCE)	18.80%	19.00%	16.20%	16.70%	68.00%	40.20%
Earnings Yield	6.89%	6.00%	4.76%	5.17%	19.34%	8.80%
FCF Yield	41.05%	32.28%	30.42%	19.70%	28.51%	21.04%
Dividend Yield	6.19%	4.72%	5.23%	4.61%	14.59%	5.42%
Payout Ratio	92.80%	76.92%	83.35%	269.85%	13.59%	69.57%
Buyback Yield / Dilution	6.50%	4.63%	0.82%	0.18%	-32.47%	-4.65%
Total Shareholder Return	12.69%	9.36%	6.04%	4.79%	-17.87%	0.77%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.